SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-006810
Filing Date
2020-02-26
Accepted
2020-02-26 16:30:23
Documents
3
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eidx-8k_20200226.htm 8-K 36399
2 EX-99.1 eidx-ex991_6.htm EX-99.1 398575
3 GRAPHIC gb2p2h34a5o4000001.jpg GRAPHIC 2631
  Complete submission text file 0001564590-20-006810.txt   439881
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38533 | Film No.: 20656172
SIC: 2834 Pharmaceutical Preparations